Genome rearrangement of influenza virus for anti-viral drug screening

Virus Research

Volumn 189, Issue , 2014, Pages 14-23

  Sutton, Troy C ^a   Obadan, Adebimpe ^a   Lavigne, Johanna ^a   Chen, Hongjun ^a   Li, Weizhong ^a   Perez, Daniel R ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

Amantadine; Anti viral screening; Gaussia luciferase; Influenza

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; LUCIFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; FEMALE; GENE EXPRESSION; INFLUENZA A; INFLUENZA VIRUS A; INVERSE POLYMERASE CHAIN REACTION; LUNG INFECTION; MDCK CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; TRANSGENE; VIRAL RESPIRATORY TRACT INFECTION; VIROGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS NEUTRALIZATION; ANIMAL; DBA MOUSE; DISEASE MODEL; DRUG EFFECTS; GENETICS; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; ORTHOMYXOVIRIDAE INFECTIONS; PROCEDURES; REPORTER GENE; VIROLOGY;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; GENE EXPRESSION; GENES, REPORTER; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUCIFERASES; MICE, INBRED DBA; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84905973185     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.05.003     Document Type: Article

References (36)

1. Brooks M.J., Burtseva E.I., Ellery P.J., Marsh G.A., Lew A.M., Slepushkin A.N., Crowe S.M., Tannock G.A. Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions. J. Med. Virol. 2012, 84(1):170-181.
2. Buxton R.C., Edwards B., Juo R.R., Voyta J.C., Tisdale M., Bethell R.C. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir. Anal. Biochem. 2000, 280(2):291-300.
3. Chua M.A., Schmid S., Perez J.T., Langlois R.A., Tenoever B.R. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Rep. 2013, 3(1):23-29.
4. Dai J., Wang G., Li W., Zhang L., Yang J., Zhao X., Chen X., Xu Y., Li K. High-throughput screening for anti-influenza A virus drugs and study of the mechanism of procyanidin on influenza A virus-induced autophagy. J. Biomol. Screening 2012, 17(5):605-617.
5. Fujii K., Fujii Y., Noda T., Muramoto Y., Watanabe T., Takada A., Goto H., Horimoto T., Kawaoka Y. Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J. Virol. 2005, 79(6):3766-3774.
6. Hayden F.G., Cote K.M., Douglas R.G. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Agents Chemother. 1980, 17(5):865-870.
7. Heaton N.S., Leyva-Grado V.H., Tan G.S., Eggink D., Hai R., Palese P. In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies. J. Virol. 2013, 87(15):8272-8281.
8. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Nat. Acad. Sci. U.S.A. 2000, 97(11):6108-6113.
9. Hossain M.J., Perez S., Guo Z., Chen L.M., Donis R.O. Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays. J. Clin. Microbiol. 2010, 48(7):2515-2523.
10. Hurt A.C., Deng Y.M., Ernest J., Caldwell N., Leang L., Iannello P., Komadina N., Shaw R., Smith D., Dwyer D.E., Tramontana A.R., Lin R.T., Freeman K., Kelso A., Barr I.G. Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region March 2009 to March 2010. Euro Surveill. 2011, 16(3):19770-19777. Bulletin Europeen sur les maladies transmissibles[[nl]]European communicable disease bulletin.
11. Jhung M.A., Swerdlow D., Olsen S.J., Jernigan D., Biggerstaff M., Kamimoto L., Kniss K., Reed C., Fry A., Brammer L., Gindler J., Gregg W.J., Bresee J., Finelli L. Epidemiology of 2009 pandemic influenza A (H1N1) in the United States. Clin. Infect. Dis. 2011, 52(Suppl 1):S13-S26.
12. Kao R.Y., Yang D., Lau L.S., Tsui W.H., Hu L., Dai J., Chan M.P., Chan C.M., Wang P., Zheng B.J., Sun J., Huang J.D., Madar J., Chen G., Chen H., Guan Y., Yuen K.Y. Identification of influenza A nucleoprotein as an antiviral target. Nat. Biotechnol. 2010, 28(6):600-605.
13. Lackenby A., Moran Gilad J., Pebody R., Miah S., Calatayud L., Bolotin S., Vipond I., Muir P., Guiver M., McMenamin J., Reynolds A., Moore C., Gunson R., Thompson C., Galiano M., Bermingham A., Ellis J., Zambon M. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill. 2011, 16(5):19784-19789. Bulletin Europeen sur les maladies transmissibles[[nl]]European communicable disease bulletin.
14. Liang Y., Hong Y., Parslow T.G. cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J. Virol. 2005, 79(16):10348-10355.
15. Manicassamy B., Manicassamy S., Belicha-Villanueva A., Pisanelli G., Pulendran B., Garcia-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Nat. Acad. Sci. U.S.A. 2010, 107(25):11531-11536.
16. Martinez-Gil L., Ayllon J., Ortigoza M.B., Garcia-Sastre A., Shaw M.L., Palese P. Identification of small molecules with type I interferon inducing properties by high-throughput screening. PLoS One 2012, 7(11):e49049.
17. Molinari N.A., Ortega-Sanchez I.R., Messonnier M.L., Thompson W.W., Wortley P.M., Weintraub E., Bridges C.B. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007, 25(27):5086-5096.
18. Morens D.M., Taubenberger J.K., Harvey H.A., Memoli M.J. The 1918 influenza pandemic: lessons for 2009 and the future. Clin. Crit. Care Med. 2010, 38(4 Suppl.):e10-e20.
19. Nguyen J.T., Hoopes J.D., Le M.H., Smee D.F., Patick A.K., Faix D.J., Blair P.J., de Jong M.D., Prichard M.N., Went G.T. Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro. PLoS One 2010, 5(2):e9332.
20. Nguyen J.T., Hoopes J.D., Smee D.F., Prichard M.N., Driebe E.M., Engelthaler D.M., Le M.H., Keim P.S., Spence R.P., Went G.T. Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro. Antimicrob. Agents Chemother. 2009, 53(10):4115-4126.
21. Ozawa M., Shimojima M., Goto H., Watanabe S., Hatta Y., Kiso M., Furuta Y., Horimoto T., Peters N.R., Hoffmann F.M., Kawaoka Y. A cell-based screening system for influenza A viral RNA transcription/replication inhibitors. Sci. Rep. 2013, 3:1106.
22. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, 1:1648-1692. Lippincott Williams and Wilkins, Philadelphia, PA, (2 vols.). fifth ed.
23. Pena L., Sutton T., Chockalingam A., Kumar S., Angel M., Shao H., Chen H., Li W., Perez D.R. Influenza viruses with rearranged genomes as live-attenuated vaccines. J. Virol. 2013, 87(9):5118-5127.
24. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S.B. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-d-N-acetylneuraminate) substrate. Anal. Biochem. 1979, 94(2):287-296.
25. Rao S., Kong W.P., Wei C.J., Yang Z.Y., Nason M., Styles D., DeTolla L.J., Panda A., Sorrell E.M., Song H., Wan H., Ramirez-Nieto G.C., Perez D., Nabel G.J. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One 2008, 3(6):e2432.
26. Reed L., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
27. Severson W.E., McDowell M., Ananthan S., Chung D.H., Rasmussen L., Sosa M.I., White E.L., Noah J., Jonsson C.B. High-throughput screening of a 100,000-compound library for inhibitors of influenza A virus (H3N2). J. Biomol. Screening 2008, 13(9):879-887.
28. Su C.Y., Cheng T.J., Lin M.I., Wang S.Y., Huang W.I., Lin-Chu S.Y., Chen Y.H., Wu C.Y., Lai M.M., Cheng W.C., Wu Y.T., Tsai M.D., Cheng Y.S., Wong C.H. High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc. Nat. Acad. Sci. U.S.A. 2010, 107(45):19151-19156.
29. Talon J., Salvatore M., O'Neill R.E., Nakaya Y., Zheng H., Muster T., Garcia-Sastre A., Palese P. Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc. Nat. Acad. Sci. U.S.A. 2000, 97(8):4309-4314.
30. Tannous B.A., Kim D.E., Fernandez J.L., Weissleder R., Breakefield X.O. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol. Ther. 2005, 11(3):435-443.
31. Ujike M., Ejima M., Anraku A., Shimabukuro K., Obuchi M., Kishida N., Hong X., Takashita E., Fujisaki S., Yamashita K., Horikawa H., Kato Y., Oguchi A., Fujita N., Tashiro M., Odagiri T. Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus Japan, 2009-2010. Emerg. Infect. Dis. 2011, 17(3):470-479.
32. Wagaman P.C., Leong M.A., Simmen K.A. Development of a novel influenza A antiviral assay. J. Virol. Methods 2002, 105(1):105-114.
33. Ye J., Sorrell E.M., Cai Y., Shao H., Xu K., Pena L., Hickman D., Song H., Angel M., Medina R.A., Manicassamy B., Garcia-Sastre A., Perez D.R. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype?. PLoS Pathog. 2010, 6(10):e1001145.
34. Zhan P., Wang L., Liu H., Chen X., Li X., Jiang X., Zhang Q., Liu X., Pannecouque C., Naesens L., De Clercq E., Liu A., Du G. Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents. Arch. Pharmacal Res. 2012, 35(6):975-986.
35. Zhang J., Liu T., Tong X., Li G., Yan J., Ye X. Identification of novel virus inhibitors by influenza A virus specific reporter cell based screening. Antiviral Res. 2011, 8:29-35.
36. Zhu W., Zhou J., Qin K., Du N., Liu L., Yu Z., Zhu Y., Tian W., Wu X., Shu Y. A reporter system for assaying influenza virus RNP functionality based on secreted Gaussia luciferase activity. Virol. J. 2011, 8:29.